Works matching IS 09509232 AND DT 2009 AND VI 28 AND IP 14

Results: 7

VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo.
Published in:
Oncogene, 2009, v. 28, n. 14, p. 1694, doi. 10.1038/onc.2009.12
By:
- Lee, C. M.;
- Hickey, M. M.;
- Sanford, C. A.;
- McGuire, C. G.;
- Cowey, C. L.;
- Simon, M. C.;
- Rathmell, W. K.
Publication type:
Article
EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells.
Published in:
Oncogene, 2009, v. 28, n. 14, p. 1706, doi. 10.1038/onc.2009.18
By:
- Fox, B. P.;
- Kandpal, R. P.
Publication type:
Article
miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.
Published in:
Oncogene, 2009, v. 28, n. 14, p. 1714, doi. 10.1038/onc.2009.19
By:
- Noonan, E. J.;
- Place, R. F.;
- Pookot, D.;
- Basak, S.;
- Whitson, J. M.;
- Hirata, H.;
- Giardina, C.;
- Dahiya, R.
Publication type:
Article
Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration.
Published in:
Oncogene, 2009, v. 28, n. 14, p. 1725, doi. 10.1038/onc.2009.20
By:
- Endo, K.;
- Kondo, S.;
- Shackleford, J.;
- Horikawa, T.;
- Kitagawa, N.;
- Yoshizaki, T.;
- Furukawa, M.;
- Zen, Y.;
- Pagano, J. S.
Publication type:
Article
Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells.
Published in:
Oncogene, 2009, v. 28, n. 14, p. 1682, doi. 10.1038/onc.2009.23
By:
- Tilman, G.;
- Loriot, A.;
- Van Beneden, A.;
- Arnoult, N.;
- Londoño-Vallejo, J. A.;
- De Smet, C.;
- Decottignies, A.
Publication type:
Article
The SWI/SNF complex and cancer.
Published in:
Oncogene, 2009, v. 28, n. 14, p. 1653, doi. 10.1038/onc.2009.4
By:
- Reisman, D.;
- Glaros, S.;
- Thompson, E. A.
Publication type:
Article
Jak2 inhibition deactivates Lyn kinase through the SET–PP2A–SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients.
Published in:
Oncogene, 2009, v. 28, n. 14, p. 1669, doi. 10.1038/onc.2009.7
By:
- Samanta, A. K.;
- Chakraborty, S. N.;
- Wang, Y.;
- Kantarjian, H.;
- Sun, X.;
- Hood, J.;
- Perrotti, D.;
- Arlinghaus, R. B.
Publication type:
Article

Works matching IS 09509232 AND DT 2009 AND VI 28 AND IP 14

VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo.

EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells.

miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.

Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration.

Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells.

The SWI/SNF complex and cancer.

Jak2 inhibition deactivates Lyn kinase through the SET–PP2A–SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients.